Estradiol Patch, Extended Release
Product Images NDC 70710-1193

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 70710-1193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 01)

Chemical structure of Estradiol showing its steroid backbone with hydroxyl groups attached. The diagram depicts the arrangement of carbon rings and functional groups characteristic of the hormone Estradiol.*

FDA Label Image

Tds-layers (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 02)

An illustration diagram showing a layer-by-layer structure of an Estradiol transdermal patch. It identifies three layers: (1) Backing, (2) Adhesive containing Estradiol, and (3) Protective liner.*

FDA Label Image

Figure-1 (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 03)

A line chart depicting estradiol plasma concentration (pg/mL) over time (days) for four different dosages of a transdermal estradiol patch: 0.1 mg/day, 0.075 mg/day, 0.05 mg/day, and 0.0375 mg/day. The graph shows concentration trends for up to 4 days post-application, with higher dosages corresponding to higher plasma concentrations.*

FDA Label Image

Estra-tw-05 (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 04)

A bar chart comparing mean (SD) reduction from baseline at Weeks 4, 8, and 12 between Estradiol Transdermal System 0.0375 mg/day (twice-weekly) and placebo. The chart displays greater reductions for the Estradiol group at each time point, with statistically significant differences indicated. Values and sample sizes are shown above each bar.*

FDA Label Image

Estra-tw-06 (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 05)

Line graph showing the percentage change from baseline over treatment duration in weeks (26, 52, 78, 104) for Estradiol Transdermal System at doses 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and placebo. The graph compares dose-dependent responses with twice-weekly administration.*

FDA Label Image

Estra-tw-07 (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 06)

Line graph depicting percent change from baseline over treatment durations of 26, 52, 78, and 104 weeks for Estradiol Transdermal System patches at doses 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, and 0.025 mg/day versus placebo. The graph shows significant differences (p<0.05) between doses A, B, C, D and placebo at multiple time points, with dose A having the highest positive change and placebo showing a negative change trend.*

FDA Label Image

0.025 mg/day (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 07)

Packaging label for Estradiol Transdermal System, USP (Twice-Weekly) delivering 0.025 mg/day. The label indicates the product contains 8 systems (patches) and is labeled for prescription use only. It includes patient instructions for application and is distributed by Zydus Pharmaceuticals USA Inc. The label also features barcodes and storage instructions.*

FDA Label Image

0.0375 mg/day (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 08)

Packaging label for Estradiol Transdermal System, USP (Twice-Weekly) delivering 0.0375 mg/day. The label states that the package includes 8 systems and is labeled for prescription use only. Manufactured by Cadila Healthcare Limited and distributed by Zydus Pharmaceuticals USA Inc. The label features instructions for use and an unvarnished area for lot and expiry information, along with a barcode and the NDC number 70710-1192-8.*

FDA Label Image

0.05 mg/day (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 09)

Packaging label for Estradiol Transdermal System, USP (Twice-Weekly) delivering 0.05 mg/day. The label indicates it includes 8 systems and is labeled for transdermal use only. Manufactured by Cadila Healthcare Limited and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes patient instructions for patch application and handling. NDC 70710-1193-8 is visible, with branding by Zydus Pharmaceuticals.*

FDA Label Image

0.075 mg/day (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 10)

This is the packaging label for Estradiol Transdermal System USP (Twice-Weekly) with a delivery strength of 0.075 mg/day. The label indicates the package contains 8 systems of an extended-release transdermal patch. It includes patient instructions for application and removal. Manufactured by Cadila Healthcare Limited and distributed by Zydus Pharmaceuticals USA Inc. The label prominently displays the dosage and directions for use on the front and sides.*

FDA Label Image

0.1 mg/day (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 11)

Packaging label for Estradiol Transdermal System, USP (Twice-Weekly) delivering 0.1 mg/day. The label indicates it includes 8 systems in the package and shows patient instructions for use. The product is distributed by Zydus Pharmaceuticals (USA) Inc. and manufactured by Cadila Healthcare Limited. The label features the Zydus Pharmaceuticals logo and specifies the product is Rx only.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 10)

An instructional line drawing illustrating the application of a transdermal patch on the back of a hand, likely for a medication such as Estradiol PATCH, EXTENDED RELEASE.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 11)

An illustration showing a hand applying a rectangular estradiol transdermal patch to the lower abdomen area of a human torso. The image demonstrates the placement site for the extended-release patch delivery.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 2)

A dosing schedule panel for Estradiol Transdermal System instructing to change the patch only on two specific days per week. Various pairs of days are listed as checkboxes, including combinations like Sun/Wed and Mon/Thu. The panel is designed to aid patients in timing their patch replacements properly.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 3)

An instructional illustration showing a hand applying a rectangular transdermal patch to the abdominal area. The diagram demonstrates correct placement of the Estradiol extended-release patch on the skin for transdermal administration.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 4)

The image shows a white rectangular transdermal patch of Estradiol extended release. The patch has a small, central marking that resembles the letter 'T'. There is no visible text or other markings on the patch. This product is manufactured by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 5)

An instructional illustration showing two hands applying or handling a small square patch, likely representing the use of a transdermal patch dosage form such as the Estradiol extended-release patch. One hand holds the patch, while the other appears to be peeling it from a backing.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 6)

An instructional line drawing showing two hands peeling apart a backing layer from a rectangular adhesive patch, illustrating the preparation step for applying a transdermal Estradiol patch. No text or dosing details are visible.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 7)

Illustration showing a hand applying a rectangular transdermal patch to the skin, demonstrating the correct placement of the Estradiol extended-release patch on the body.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 8)

An instructional line drawing showing two hands; one hand is holding a ring-shaped patch with a central hole, while the other hand is about to apply or place the patch on the first hand's finger. The illustration appears to demonstrate the application or handling of a transdermal patch dosage form.*

FDA Label Image

Image (Fabe46eb 9f99 46e5 Bedd 677cc99a024d 571 9)

An instructional illustration showing hands applying a small square patch to a finger. The image likely depicts the application method for a transdermal medication patch, consistent with the use of estradiol extended release patches.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.